|
Coletti, M., & Europa, I. T. A. C. A. (1996). Evaluation of treatment of drug abuse (various, Ed.). Roma: Cedis Editrice.
Keywords: treatment and maintenance
|
|
|
Bundesamt für Gesundheit, Office fédéral de la santé publique, & Ufficio federale della sanità pubblica. (1995). Echomedia 17 : ärztliche Verschreibung von Betäubungsmitteln = prescription médicale de stupéfiants = Prescrizione medicale di stupefacenti (various, Ed.). Bern: Bundesamt für Gesundheit (BAG); Office fédéral de la santé publique (OFSP); Ufficio federale della sanità pubblica (UFSP).
Keywords: treatment and maintenance; outpatient care
|
|
|
Rihs-Middel, M., Lotti, H., Stamm, R., Clerc, J. - M., & Bundesamt für Gesundheit. (1996). Ärztliche Verschreibung von Betäubungsmitteln : wissenschaftliche Grundlagen und praktische Erfahrungen (various, Ed.). Bern; Göttingen; Toronto; Seattle: H. Huber.
Keywords: treatment and maintenance; outpatient care; laws and regulations; Switzerland; Germany; United Kingdom; Australia; Netherlands; United States
|
|
|
Bundesamt für Gesundheit, Office fédéral de la santé publique, & Federal Office of Public Health. (2000). Suchtforschung des BAG 1996-98 : Band 1/4 : Grundlagenforschung = Recherches de l'OFSP en matière de dépendances 1996-98 : volume 1/4 : recherche fondamentale (B. für Gesundheit, O. fédéral de la santé publique, & Federal Office of Public Health, Eds.). Bern; Berne: Bundesamt für Gesundheit (BAG); Office fédéral de la santé publique (OFSP); Swiss Federal Office of Public Health (SFOPH).
Keywords: research; health services, prevention, and treatment research; research in general; multiple sclerosis; tetrahydrocannabinol; cannabis product; MDMA; ecstasy; electroencephalography; emotion; serotonin; dopamine; norepinephrine; volunteer health care worker; methadone; genetic polymorphism; individual differences; buprenorphine; AOD dependence; opioids in any form; methadone maintenance; randomized controlled trial; pharmacodynamics; physiology; hypoventilation; urinalysis; hair analysis; sweat analysis; social cost of AOD; quality of life; cost-benefit analysis; search and seizure; adulteration; quantitative data analysis; opioid contaminant; law enforcement agency; AOD consumption; heroin; deoxyhemoglobin; spectroscopy; liposomes; pulmonary administration; heroin-assisted treatment; trial study; AOD use and driving; cognitive ability; epidemiological indicators; smoking; tobacco product; health and disease; general population survey; AOD demand; factor analysis; price elasticity of demand; knowledge, attitudes, and practices; taxes; cessation of AODU; population dynamics; occasional AOD use; behavioral change; stages of change; AODR mortality; prevalence; outpatient care; professional counseling; counseling service; program planning, implementation, and evaluation; organizational development; content analysis; psychoactive substances; antianxiety tranquilizers; narcotic analgesics; laxatives; cough syrup; appetite suppressants; gender; epidemiology; nightlife; urban area; AOD use pattern; designer drug; research chemical; illicit drug; sociology; cocaine; protective factors; estimation; mathematical model; incidence; harm reduction; drug user; drug evaluation; drug safety; dissemination of warnings; dissemination of AODE information; adolescent; underage smoking; AOD prevention; risk factors; lipids; heart disorder; case management; alcohol dependence; disease severity; validation study; AODR disability; primary health care; physician; identification and screening; alcohol use test; CAGE Questionnaire; AOD use, abuse, and dependence; comorbidity; treatment and maintenance; morbidity; economic cost of AODU; treatment cost; health care costs; human resources; labor costs; Switzerland; Europe; drug substitution therapy
|
|
|
International Federation of Red Cross and Red Crescent Societies. (2003). Spreading the light of science : guidelines on harm reduction related to injecting drug use. Geneva: Author.
Abstract: This document details the rationale for harm reduction programmes. It outlines generic approaches that National Societies can adapt to the realities of their countries in the development and implementation of harm reduction programme and in conducting advocacy for the acceptance and realization such programmes.
Keywords: harm reduction; program planning, implementation, and evaluation; advocacy; recommendations or guidelines; international area
|
|
|
United Nations Office on Drugs and Crime, & Laboratory and Scientific Section. (2003). Terminology and information on drugs. New York: United Nations (UN).
Abstract: This publication is intended to give a brief description of the most frequently encountered drugs, as well as definitions of the most relevant scientific terms used in this context. While the publication is by no means exhaustive, it provides basic, generally accepted information on selected drugs of abuse, their abuse patterns, pharmacological effects and medical use, if any.
Keywords: AOD use, abuse, and dependence; chemical addiction; cannabis; cocaine in any form; opium; opioids in any form; CNS depressants; stimulants; hallucinogens; AOD effects and consequences; pharmacology and toxicology; reference work; glossary
|
|
|
Department of Health and Ageing (Ed.). (2003). 2002 reviews of the National HIV/AIDS and Hepatitis C Strategies and strategic research. Canberra: Commonwealth of Australia.
Keywords: government and politics; strategy; HIV infection; viral hepatitis; hepatitis C; international area; Australia
|
|
|
Bundesamt für Statistik. (2009). Statistik der sozialmedizinischen Institutionen 2007 : Standardtabellen : definitive Resultate. Neuchâtel: Bundesamt für Statistik (BFS).
Keywords: health care program or facility; statistical data; Switzerland
|
|
|
Prometa (Ed.). (2006). Prometa-Werbemappe : Handbuch zur Beratung von Patienten = Manuel à l'usage du patient = Patient education book. Montreux: Prometa.
Keywords: treatment and maintenance
|
|
|
Institut pour la recherche sur la toxicomanie, & Ligue pour l'évaluation de traitements résidentiels de la toxicomanie. (1996). Questionnaire d'évaluation pour l'ensemble des centres résidentiels de traitement de la toxicomanie en Suisse : listes 1-4. Zurich: Institut pour la recherche sur la toxicomanie (ISF); Ligue pour l'évaluation de traitements résidentiels de la toxicomanie (FOS).
Keywords: treatment and maintenance; inpatient care
|
|